RNA & Molecular Recognition
Researching how RNA structures and molecular-recognition systems can make low-abundance signals visible.
RNA × ULTRASENSITIVE DETECTION × AI × CODE
Geno10X is advancing research at the intersection of attomolar-scale molecular detection, rapid biosensing and AI-enabled analysis—toward earlier insight into cancer and other diseases.
Molecular intelligence pipeline
A connected research workflow brings molecular recognition, sensor response and computational analysis into one reproducible path.
Four connected research layers
Geno10X connects complementary research layers so that low-abundance molecular signals can move through a disciplined path from experiment to interpretable research insight.
Researching how RNA structures and molecular-recognition systems can make low-abundance signals visible.
Connecting amplification, fluorogenic response and rapid sensor readout while keeping published sensitivity results in their exact scientific context.
Developing models that structure experimental signals, extract features and support research-stage pattern analysis.
Engineering reproducible digital workflows that connect assay development, data review and future product translation.
Early-detection application thesis
Low-abundance molecular signals may matter in early-disease research. Sensitivity must be developed alongside specificity, reproducibility, validation and responsible interpretation.
Published molecular-sensing studies provide scientific context for attomolar-scale detection under defined experimental methods. They do not establish Geno10X product performance.
Explore molecular-recognition and amplification approaches for signals that may be difficult to observe.
Structure experimental readouts so models and researchers can review them consistently.
Advance sensitivity together with specificity, evidence quality and research-stage safeguards.

Flagship public research program
The public program explores highly sensitive urine-based HPV detection, sensor science and AI-supported risk assessment. It is a research collaboration—not the limit of Geno10X’s disease-research scope.
SourceThe official Innovate BC record describes collaboration among Geno10X Biosciences, Gene Bio Medical and researchers at Simon Fraser University. The NSERC Alliance project is a separate related public record.
Science & Publications
The platform is informed by peer-reviewed molecular science and transparent public research records. Source context stays attached to every scientific claim.
An overview of RNA Mango as a fluorogenic aptamer used in RNA imaging and detection research.
Simon Fraser University — Open primary sourceThe paper reports 2.5 aM under its published experimental method. This is published scientific context, not a Geno10X performance claim.
RNA Journal — Open primary sourceThe official announcement records the C$300,000 Innovate BC Ignite award and the participating research organizations.
Innovate BC — Open primary sourceCollaborate
Geno10X works across molecular research, sensing systems, computational methods and responsible translation. Choose the pathway that best matches your contribution.
Connect complementary molecular methods, experimental systems and disease-research questions.
Combine research-stage sensing, analytical or engineering capabilities within a defined program.
Shape reproducible workflows that can move promising research toward real-world use.
Explore aligned programs, institutional relationships and long-term development pathways.